Assertio Logo.jpg
Assertio Reports Fourth Quarter and Full Year 2022 Financial Results
08 mars 2023 16h01 HE | Assertio Holdings, Inc.
Net Product Sales Increase 55% in the Fourth Quarter, 42% for the Full Year Full Year Net Income Increases to $109.6 Million, Non-GAAP Adjusted EBITDA Increases to $101.6 Million Cash Flows from...
Assertio Logo.jpg
Assertio Holdings, Inc. Announces Preliminary Fourth Quarter and Full Year 2022 Results
21 févr. 2023 07h00 HE | Assertio Holdings, Inc.
Year-over-Year Net Product Sales Increased at Least 54% for the Fourth Quarter and 41% for the Full Year Cash Flows from Operations Was at Least $26 Million for the Fourth Quarter and $78 Million for...
Assertio Logo.jpg
Assertio to Participate in the 2023 SVB Securities Global Biopharma Conference
08 févr. 2023 08h00 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Logo.jpg
Assertio to Participate in October 2022 Investor Conferences
12 oct. 2022 07h30 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Logo.jpg
Assertio Announces Closing of $70 Million Convertible Senior Notes Offering
25 août 2022 10h24 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Logo.jpg
Assertio Reports Second Quarter 2022 Financial Results
08 août 2022 07h00 HE | Assertio Holdings, Inc.
Net Product Sales Increase 40% Year-Over-Year, Non-GAAP Adjusted EBITDA Increases to $22.9 million Raises Full Year Revenue and Non-GAAP Adjusted EBITDA Guidance LAKE FOREST, Ill., Aug. 08, 2022 ...
Investors for Opioid
Investors for Opioid Accountability Commends Endo International plc for Board of Directors’ Opioid Oversight Report
06 déc. 2018 09h05 HE | UAW Retiree Medical Benefits Trust
Detroit, Michigan, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Investors for Opioid Accountability (IOA), a coalition of 53 institutional investors with over $3.4 trillion in assets, commends Endo...